How do I transition from active treatment to surveillance for Colorectal Cancer

Transitioning from Active Treatment to Surveillance for Colorectal Cancer

This is an important transition in your cancer journey. Let me walk you through what this shift looks like and what you should expect.

Understanding the Shift in Your Care

When you finish active treatment (surgery, chemotherapy, or radiation), your care team moves from trying to eliminate cancer to monitoring for any signs of recurrence (cancer returning). This is called surveillance, and it's a structured, evidence-based approach—not just "watching and waiting."

According to NCCN Guidelines Version 5.2025, the goal of surveillance is to:

• Identify any recurrence early when it might still be treatable with surgery
• Detect new cancers or precancerous polyps
• Monitor for long-term side effects from your treatment
• Support your overall health and wellness

Your Surveillance Schedule (Based on Your Stage)

The frequency and type of monitoring depends on your cancer stage:

Stage I Disease

• History and physical exam: Every 3-6 months for 2 years, then every 6 months for a total of 5 years
• Colonoscopy: At 1 year after surgery (or 3-6 months if surgery was done for an obstructing tumor)
  • If advanced adenoma found: repeat in 1 year
  • If no advanced adenoma: repeat in 3 years, then every 5 years
• CEA blood test: Not routinely needed for Stage I
• CT scans: Not routinely recommended
• After 5 years: Surveillance can be less intensive

Stage II or III Disease

• History and physical exam: Every 3-6 months for 2 years, then every 6 months for a total of 5 years
• CEA blood test: Every 3-6 months for 2 years, then every 6 months for a total of 5 years (if you're a candidate for surgery if recurrence is found)
• Chest/Abdomen/Pelvis CT scan: Every 6-12 months for a total of 5 years
• Colonoscopy: Same schedule as Stage I
• After 5 years: Routine CEA and CT monitoring are not recommended

Stage IV Disease (if managed with complete response)

• More intensive monitoring with CT scans every 3-6 months for the first 2 years
• Then every 6-12 months for a total of 5 years

What These Tests Actually Do

CEA (Carcinoembryonic Antigen) Blood Test

• Measures a protein that can be elevated in colorectal cancer
• Helps detect recurrence earlier than symptoms would appear
• Rising CEA levels may prompt further imaging

CT Scans (Chest, Abdomen, Pelvis)

• Looks for signs of cancer returning in your organs
• Helps identify metastatic disease (cancer that has spread) that might be surgically removable
• Research shows intensive imaging helps identify more patients who could benefit from surgery for recurrence

Colonoscopy

• Checks for new polyps or precancerous changes
• Allows removal of polyps before they become cancer
• Critical for preventing new cancers

Important Note: According to NCCN Guidelines, PET/CT scans are NOT routinely recommended for surveillance, and circulating tumor DNA (ctDNA) testing is not recommended for routine surveillance at this time.

The Transition Process: What to Expect

Before Your Last Treatment

Ask your oncology team:

1. "What is my cancer stage and what does that mean for my surveillance plan?"
2. "When should my surveillance schedule start?"
3. "Who will coordinate my surveillance—my oncologist, primary care doctor, or both?"
4. "What symptoms should I report immediately between appointments?"

At Your Last Treatment Visit

Your care team should provide:

• A survivorship care plan (written summary of your treatment and follow-up schedule)
• Clear instructions on who to contact for different concerns
• Information about managing side effects from treatment
• Recommendations for healthy lifestyle changes

During Early Surveillance (Months 1-24)

• More frequent visits (every 3-6 months)
• Regular blood work and imaging
• Close monitoring for treatment side effects
• Adjustment of your care plan if needed

Later Surveillance (Years 2-5)

• Visits become less frequent (every 6 months)
• Continued imaging and blood work
• Focus shifts toward managing long-term effects and prevention

After 5 Years

• Surveillance becomes less intensive
• Routine cancer screening continues (colonoscopy every 5 years)
• Ongoing primary care and preventive health screening

Important Questions to Ask Your Care Team

1. "What is my specific surveillance schedule based on my stage and risk factors?"

   • This ensures you understand YOUR plan, not a generic one

2. "If my CEA rises or imaging shows something concerning, what happens next?"

   • Understanding the decision-making process reduces anxiety

3. "How will my oncologist and primary care doctor communicate about my care?"

   • Clear coordination prevents gaps in monitoring

4. "What symptoms or changes should I report immediately versus at my next appointment?"

   • Knowing what's urgent helps you respond appropriately

5. "Are there any clinical trials I should consider during surveillance?"

   • New treatments and monitoring approaches are constantly being studied

6. "What can I do to reduce my risk of recurrence?"

   • Lifestyle factors matter (see below)

Managing Long-Term Side Effects During Surveillance

According to NCCN Survivorship Guidelines, common issues include:

• Chronic diarrhea or bowel changes: Anti-diarrheal medications, dietary changes, pelvic floor rehabilitation
• Neuropathy (nerve damage from chemotherapy): Duloxetine may help with pain; heat therapy or acupuncture can be considered
• Fatigue: Exercise, sleep management, counseling
• Emotional distress: Counseling, support groups, distress screening

Healthy Lifestyle Recommendations

During surveillance, focus on:

• Physical activity: At least 30 minutes of moderate-intensity activity most days
• Healthy diet: Emphasis on plant-based foods (adjust if you have bowel dysfunction)
• Healthy weight: Maintain throughout your life
• Aspirin: Consider 325 mg daily for secondary prevention (discuss risks/benefits with your doctor)
• Alcohol: Drink sparingly, if at all
• Smoking: Quit if applicable
• Cancer screening: Stay current with age-appropriate screenings (mammography, etc.)

The Role of Your Care Team

According to NCCN Guidelines, your oncologist and primary care doctor should have clearly defined roles:

• Oncologist: Manages cancer-specific surveillance, interprets tumor markers, handles cancer recurrence
• Primary Care Doctor: Manages overall health, preventive care, other medical conditions, coordinates with oncology

Make sure these roles are communicated to you in writing.

Key Takeaway

Transitioning to surveillance is not the end of your cancer care—it's a shift to a different, structured approach focused on early detection and long-term health. The good news is that 80% of recurrences occur in the first 3 years, so intensive early surveillance is most important during that period.

---

Specific Questions to Bring to Your Next Appointment

1. What is my exact surveillance schedule for the next 5 years?
2. Who coordinates my care between oncology and primary care?
3. What should I do if I develop new symptoms between appointments?
4. Are there any biomarkers or tests specific to my tumor type I should know about?
5. What is my risk of recurrence based on my specific pathology?

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.